Valsartan Increases Circulating Adiponectin Levels without Changing HOMA-IR in Patients with Type 2 Diabetes Mellitus and Hypertension

Author： Lee J-M   Kim J-H   Son H-S   Hong E-G   Yu J-M   Han K-A   Min K-W   Chang S-A  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.38, Iss.1, 2010-01, pp. : 234-241

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment with rosiglitazone reduces ambulatory BP and increases insulin sensitivity in patients with hypertension and type 2 diabetes mellitus

By  

Inpharma, Vol. 1, Iss. 1458, 2004-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Effect of various treatments on leptin, adiponectin, ghrelin and neuropeptide Y in patients with type 2 diabetes mellitus

By Katsiki Niki   Mikhailidis Dimitri P   Gotzamani-Psarrakou Anna   Yovos John G   Karamitsos Dimitrios  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 4, 2011-04 ,pp. : 401-420

Informa Healthcare

Access to resources Recommend Favorite

Independent Relationship of Osteocalcin Circulating Levels with Obesity, Type 2 Diabetes, Hypertension, and HDL Cholesterol

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 16, Iss. 4, 2017-02 ,pp. : 270-275

Bentham Science Publishers

Access to resources Recommend Favorite

-Blockers in the Management of Hypertension in Patients with Type 2 Diabetes Mellitus: Is There a Role?

By Dunne F.   Kendall M.J.   Martin U.  

Drugs, Vol. 61, Iss. 4, 2001-01 ,pp. : 429-435

Adis International

Access to resources Recommend Favorite

Effects on Blood Pressure of the -Glucosidase Inhibitor Acarbose Compared with the Insulin Enhancer Glibenclamide in Patients with Hypertension and Type 2 Diabetes Mellitus

By Rosenthal J.H.   Mauersberger H.  

Clinical Drug Investigation, Vol. 22, Iss. 10, 2002-01 ,pp. : 695-701

Adis International

Access to resources Recommend Favorite